<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rentrad</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник рентгенологии и радиологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of radiology and nuclear medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0042-4676</issn><issn pub-type="epub">2619-0478</issn><publisher><publisher-name>Limited Liability Company "LUCHEVAYA DIAGNOSTIKA", Russian Association of Radiologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20862/0042-4676-2024-105-6-314-324</article-id><article-id custom-type="elpub" pub-id-type="custom">rentrad-937</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Левамизол-индуцированная лейкоэнцефалопатия: редкий случай побочного действия препарата</article-title><trans-title-group xml:lang="en"><trans-title>Levamisole-induced leukoencephalopathy: a rare drug side effect</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6264-1880</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ельшибаева</surname><given-names>Э. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Yelshibayeva</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ельшибаева Эльмира Сериккалиевна, PhD, заведующая отделением компьютерной томографии и магнитно-резонансной томографии; доцент Научно-исследовательского института радиологии им. академика Ж.Х. Хамзабаева</p><p>пр-т Мангилик Ел, 80, Астана, 010000</p></bio><bio xml:lang="en"><p>Elmira S. Yelshibayeva, PhD, Head of the Department of Computed Tomography and Magnetic Resonance Imaging; Associate Professor</p><p>prospekt Mangilik El, 80, Astana, 010000</p><p>ul. Beibytshilyk, 49/А, Astana, 010000</p></bio><email xlink:type="simple">elmiraelsibaeva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-4877-3625</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суйгенбаева</surname><given-names>А. Ж.</given-names></name><name name-style="western" xml:lang="en"><surname>Suigenbayev</surname><given-names>A. Zh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Суйгенбаева Айгерим Жорабековна, врач радиолог</p><p>пр-т Мангилик Ел, 80, Астана, 010000</p></bio><bio xml:lang="en"><p>Aigerim Zh. Suigenbayeva, Radiologist</p><p>prospekt Mangilik El, 80, Astana, 010000</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-2488-5911</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мергалимова</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Mergalimova</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мергалимова Акерке Бакытбеккызы, врач резидент – радиолог</p><p>пр-т Мангилик Ел, 80, Астана, 010000</p></bio><bio xml:lang="en"><p>Akerke B. Mergalimova, Resident Radiologist</p><p>prospekt Mangilik El, 80, Astana, 010000</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-5017-1484</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Оспанова</surname><given-names>Ж. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Ospanova</surname><given-names>Zh. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оспанова Жанар Бахытжановна, врач невролог</p><p>пр-т Мангилик Ел, 80, Астана, 010000</p></bio><bio xml:lang="en"><p>Zhanar B. Ospanova, Neurologist</p><p>prospekt Mangilik El, 80, Astana, 010000</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>РГП «Больница Медицинского центра Управления делами Президента Республики Казахстан» на ПХВ; НАО «Медицинский университет Астана»</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan; Astana Medical University</institution><country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>РГП «Больница Медицинского центра Управления делами Президента Республики Казахстан» на ПХВ</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan</institution><country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>25</day><month>07</month><year>2025</year></pub-date><volume>105</volume><issue>6</issue><fpage>314</fpage><lpage>324</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ельшибаева Э.С., Суйгенбаева А.Ж., Мергалимова А.Б., Оспанова Ж.Б., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Ельшибаева Э.С., Суйгенбаева А.Ж., Мергалимова А.Б., Оспанова Ж.Б.</copyright-holder><copyright-holder xml:lang="en">Yelshibayeva E.S., Suigenbayev A.Z., Mergalimova A.B., Ospanova Z.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.russianradiology.ru/jour/article/view/937">https://www.russianradiology.ru/jour/article/view/937</self-uri><abstract><p>Левамизол – противопаразитарное лекарственное средство, широко использующееся в клинической практике. Одним из редких побочных действий препарата является развитие левамизол-индуцированной мультифокальной воспалительной лейкоэнцефалопатии, которая прогрессирует через 2–8 нед после лечения и характеризуется демиелинизацией головного мозга и поражением белого вещества. В статье описан случай левамизол-индуцированной лейкоэнцефалопатии, которую необходимо дифференцировать с рассеянным склерозом, острым рассеянным энцефаломиелитом и оптиконейромиелитом.</p></abstract><trans-abstract xml:lang="en"><p>Levamisole is an antihelminthic drug that is widely used in clinical practice. One of its rare side effects is the development of levamisole-associated multifocal inflammatory leukoencephalopathy, which progresses 2–8 weeks after treatment and is characterized by brain demyelination and white matter damage. The article describes a case of levamisole-induced leukoencephalopathy, which should be differentiated from multiple sclerosis, acute disseminated encephalomyelitis, and neuromyelitis optica.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>левамизол</kwd><kwd>левамизол-индуцированная лейкоэнцефалопатия</kwd><kwd>левамизол-индуцированная мультифокальная воспалительная лейкоэнцефалопатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>levamisole</kwd><kwd>levamisole-induced leukoencephalopathy</kwd><kwd>levamisole-associated multifocal inflammatory leukoencephalopathy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы выражают благодарность сотрудникам отделения компьютерной томографии и магнитно-резонансной томографии РГП «Больница Медицинского центра Управления делами Президента Республики Казахстан» на ПХВ, а также редакции журнала за возможность опубликовать результаты своей работы.</funding-statement><funding-statement xml:lang="en">The authors express their gratitude to the staff of Department of Computed Tomography and Magnetic Resonance Imaging, Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, as well as to the editors of the journal for the opportunity to publish the results of their work.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Howelland M, Prevenier W. From reliable sources: an introduction to historical methods. Cornell University Press; 2001: 77 pp.</mixed-citation><mixed-citation xml:lang="en">Howelland M, Prevenier W. From reliable sources: an introduction to historical methods. Cornell University Press; 2001: 77 pp.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson JS, Herbick JM, Klassen LW, et al. Studies on levamisole-induced agranulocytosis. Blood. 1980; 56(3): 388–96.</mixed-citation><mixed-citation xml:lang="en">Thompson JS, Herbick JM, Klassen LW, et al. Studies on levamisole-induced agranulocytosis. Blood. 1980; 56(3): 388–96.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Scheinfeld N, Rosenberg JD, Weinberg JM. Levamisole in dermatology: a review. Am J Clin Dermatol. 2004; 5(2): 97–104. https://doi.org/10.2165/00128071-200405020-00004.</mixed-citation><mixed-citation xml:lang="en">Scheinfeld N, Rosenberg JD, Weinberg JM. Levamisole in dermatology: a review. Am J Clin Dermatol. 2004; 5(2): 97–104. https://doi.org/10.2165/00128071-200405020-00004.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New Engl J Med. 1990; 322(6): 352–8. https://doi.org/10.1056/NEJM199002083220602.</mixed-citation><mixed-citation xml:lang="en">Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New Engl J Med. 1990; 322(6): 352–8. https://doi.org/10.1056/NEJM199002083220602.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wolford A, McDonald TS, Eng H, et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos. 2012; 40(6): 1067–75. https://doi.org/10.1124/dmd.112.045021.</mixed-citation><mixed-citation xml:lang="en">Wolford A, McDonald TS, Eng H, et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos. 2012; 40(6): 1067–75. https://doi.org/10.1124/dmd.112.045021.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rongioletti F, Ghio L, Ginevri F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol. 1999; 140(5): 948–51. https://doi.org/10.1046/j.1365-2133.1999.02833.x.</mixed-citation><mixed-citation xml:lang="en">Rongioletti F, Ghio L, Ginevri F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol. 1999; 140(5): 948–51. https://doi.org/10.1046/j.1365-2133.1999.02833.x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Karch SB, Mari F, Bartolini V, Bertol E. Aminorex poisoning in cocaine abusers. Int J Cardiol. 2012; 158(3): 344–6. https://doi.org/10.1016/j.ijcard.2011.06.105.</mixed-citation><mixed-citation xml:lang="en">Karch SB, Mari F, Bartolini V, Bertol E. Aminorex poisoning in cocaine abusers. Int J Cardiol. 2012; 158(3): 344–6. https://doi.org/10.1016/j.ijcard.2011.06.105.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">WHO model list of essential medicines – 21st list, 2019. Available at: https://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06 (accessed 03.11.2024).</mixed-citation><mixed-citation xml:lang="en">WHO model list of essential medicines – 21st list, 2019. Available at: https://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06 (accessed 03.11.2024).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Campillo JT, Eiden C, Boussinesq M, et al. Adverse reactions with levamisole vary according to its indications and misuse: a systematic pharmacovigilance study. Br J Clin Pharmacol. 2022; 88(3): 1094–106. https://doi.org/10.1111/bcp.15037.</mixed-citation><mixed-citation xml:lang="en">Campillo JT, Eiden C, Boussinesq M, et al. Adverse reactions with levamisole vary according to its indications and misuse: a systematic pharmacovigilance study. Br J Clin Pharmacol. 2022; 88(3): 1094–106. https://doi.org/10.1111/bcp.15037.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Larocque A, Hoffman RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol. 2012; 50(4): 231–41. https://doi.org/10.3109/15563650.2012.665455.</mixed-citation><mixed-citation xml:lang="en">Larocque A, Hoffman RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol. 2012; 50(4): 231–41. https://doi.org/10.3109/15563650.2012.665455.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Midthun KM, Nelson LS, Logan BK. Levamisole – a toxic adulterant in illicit drug preparations: a review. Ther Drug Monit. 2021; 43(2): 221−8. https://doi.org/10.1097/FTD.851.</mixed-citation><mixed-citation xml:lang="en">Midthun KM, Nelson LS, Logan BK. Levamisole – a toxic adulterant in illicit drug preparations: a review. Ther Drug Monit. 2021; 43(2): 221−8. https://doi.org/10.1097/FTD.851.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zakharova M, Zakroyshchikova I, Kozlova A, et al. Levamisole-induced leukoencephalopathy in Russia: analysis of 30 cases. Curr Drug Saf. 2022; 17(4): 319–26. https://doi.org/10.2174/1574886317666211224121517.</mixed-citation><mixed-citation xml:lang="en">Zakharova M, Zakroyshchikova I, Kozlova A, et al. Levamisole-induced leukoencephalopathy in Russia: analysis of 30 cases. Curr Drug Saf. 2022; 17(4): 319–26. https://doi.org/10.2174/1574886317666211224121517.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Brunt TM, van den Berg J, Pennings E, Venhuis B. Adverse effects of levamisole in cocaine users: a review and risk assessment. Arch Toxicol. 2017; 91(6): 2303–13. https://doi.org/10.1007/s00204-017-1947-4.</mixed-citation><mixed-citation xml:lang="en">Brunt TM, van den Berg J, Pennings E, Venhuis B. Adverse effects of levamisole in cocaine users: a review and risk assessment. Arch Toxicol. 2017; 91(6): 2303–13. https://doi.org/10.1007/s00204-017-1947-4.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wu VC, Huang JW, Lien HC, et al. Levamisole-induced multifocal inflammatory leukoencephalopathy: clinical characteristics, outcome, and impact of treatment in 31 patients. Medicine. 2006; 85(4): 203–13. https://doi.org/10.1097/01.md.0000230250.95281.60.</mixed-citation><mixed-citation xml:lang="en">Wu VC, Huang JW, Lien HC, et al. Levamisole-induced multifocal inflammatory leukoencephalopathy: clinical characteristics, outcome, and impact of treatment in 31 patients. Medicine. 2006; 85(4): 203–13. https://doi.org/10.1097/01.md.0000230250.95281.60.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hook CC, Kimmel DW, Kvols LK, et al. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol. 1992; 31(3): 262–7. https://doi.org/10.1002/ana.410310306.</mixed-citation><mixed-citation xml:lang="en">Hook CC, Kimmel DW, Kvols LK, et al. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol. 1992; 31(3): 262–7. https://doi.org/10.1002/ana.410310306.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fassas AB, Gattani AM, Morgello S. Cerebral demyelination with 5-fluorouracil and levamisole. Cancer Invest. 1994; 12(4): 379–83. https://doi.org/10.3109/07357909409038226.</mixed-citation><mixed-citation xml:lang="en">Fassas AB, Gattani AM, Morgello S. Cerebral demyelination with 5-fluorouracil and levamisole. Cancer Invest. 1994; 12(4): 379–83. https://doi.org/10.3109/07357909409038226.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kimmel DW, Wijdicks EF, Rodriguez M. Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology. 1995; 45(2): 374–6. https://doi.org/10.1212/wnl.45.2.374.</mixed-citation><mixed-citation xml:lang="en">Kimmel DW, Wijdicks EF, Rodriguez M. Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology. 1995; 45(2): 374–6. https://doi.org/10.1212/wnl.45.2.374.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Luppi G, Zoboli A, Barbieri F, et al. Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer. A report of two cases and review of the literature. The INTACC. Intergruppo Nazionale Terpia Adiuvante Colon Carcinoma. Ann Oncol. 1996; 7(4): 412–5. https://doi.org/10.1093/oxfordjournals.annonc.a010610.</mixed-citation><mixed-citation xml:lang="en">Luppi G, Zoboli A, Barbieri F, et al. Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer. A report of two cases and review of the literature. The INTACC. Intergruppo Nazionale Terpia Adiuvante Colon Carcinoma. Ann Oncol. 1996; 7(4): 412–5. https://doi.org/10.1093/oxfordjournals.annonc.a010610.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Liu HM, Hsieh WJ, Yang CC, et al. Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers. Neurology. 2006; 67(6): 1065–7. https://doi.org/10.1212/01.wnl.0000237344.06122.79.</mixed-citation><mixed-citation xml:lang="en">Liu HM, Hsieh WJ, Yang CC, et al. Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers. Neurology. 2006; 67(6): 1065–7. https://doi.org/10.1212/01.wnl.0000237344.06122.79.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Xu N, Zhou W, Li S, et al. Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients. J Neuroimaging. 2009; 19(4): 326–31. https://doi.org/10.1111/j.1552-6569.2008.00344.x.</mixed-citation><mixed-citation xml:lang="en">Xu N, Zhou W, Li S, et al. Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients. J Neuroimaging. 2009; 19(4): 326–31. https://doi.org/10.1111/j.1552-6569.2008.00344.x.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Figueredo AT, Fawcet SE, Molloy DW, et al. Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant therapy for resected colorectal cancer: a report of two cases. Cancer Invest. 1995; 13(6): 608–11. https://doi.org/10.3109/07357909509024930.</mixed-citation><mixed-citation xml:lang="en">Figueredo AT, Fawcet SE, Molloy DW, et al. Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant therapy for resected colorectal cancer: a report of two cases. Cancer Invest. 1995; 13(6): 608–11. https://doi.org/10.3109/07357909509024930.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Cossaart N, SantaCruz KS, Preston D, et al. Fatal chemotherapy-induced encephalopathy following highdose therapy for metastatic breast cancer: a case report and review of the literature. Bone Marrow Transpl. 2003; 31(1): 57–60. https://doi.org/10.1038/sj.bmt.1703768.</mixed-citation><mixed-citation xml:lang="en">Cossaart N, SantaCruz KS, Preston D, et al. Fatal chemotherapy-induced encephalopathy following highdose therapy for metastatic breast cancer: a case report and review of the literature. Bone Marrow Transpl. 2003; 31(1): 57–60. https://doi.org/10.1038/sj.bmt.1703768.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Chastel C, Mabin D. Encephalopathies after levamisole therapy. Neurology. 1996; 46(1): 288. https://doi.org/10.1212/wnl.46.1.288.</mixed-citation><mixed-citation xml:lang="en">Chastel C, Mabin D. Encephalopathies after levamisole therapy. Neurology. 1996; 46(1): 288. https://doi.org/10.1212/wnl.46.1.288.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng R. Differential diagnosis of delayed encephalopathy induced by anthelmintic imidazoles. Zhonghua Nei Ke Za Zhi. 1995; 34(7): 468–71 (in Chinese).</mixed-citation><mixed-citation xml:lang="en">Zheng R. Differential diagnosis of delayed encephalopathy induced by anthelmintic imidazoles. Zhonghua Nei Ke Za Zhi. 1995; 34(7): 468–71 (in Chinese).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lucchinetti CF, Kimmel DW, Pavelko K, Rodriguez M. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus. Exp Neurol. 1997; 147(1): 123–9. https://doi.org/10.1006/exnr.1997.6598.</mixed-citation><mixed-citation xml:lang="en">Lucchinetti CF, Kimmel DW, Pavelko K, Rodriguez M. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus. Exp Neurol. 1997; 147(1): 123–9. https://doi.org/10.1006/exnr.1997.6598.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018; 17(2): 162–73. https://doi.org/10.1016/S1474-4422(17)30470-2.</mixed-citation><mixed-citation xml:lang="en">Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018; 17(2): 162–73. https://doi.org/10.1016/S1474-4422(17)30470-2.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013; 84(8): 909–14. https://doi.org/10.1136/jnnp-2012-304695.</mixed-citation><mixed-citation xml:lang="en">Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013; 84(8): 909–14. https://doi.org/10.1136/jnnp-2012-304695.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
